DOCSLIB.ORG

Cannabis a Practical Guide SECOND EDITION How to Regulate Cannabis a Practical Guide How to Regulate Cannabis a Practical Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cannabis a Practical Guide SECOND EDITION How to Regulate Cannabis a Practical Guide How to Regulate Cannabis a Practical Guide How to Regulate Cannabis A Practical Guide SECOND EDITION How to Regulate Cannabis A Practical Guide How to Regulate Cannabis A Practical Guide SECOND EDITION Updated October 2016 Transform Drug Policy Foundation Getting drugs under control Transform Drug Policy Foundation is an international, charitable think tank with staff in the UK and Mexico. We are working to get drugs under control by advocating for strict regulation of all aspects of the drug trade. We aim to equip policy makers and reform advocates with the tools they need to fundamentally change our current approach to drugs and create a healthier, safer world. Transform emerged in response to the increasingly apparent failings of current national and international drug policy. We draw attention to the fact that drug prohibition itself is the major cause of drug-related harm to individuals, communities and nations, and should be replaced by effective, just and humane government control and regulation. We provide evidence-based critiques of the war on drugs, new thinking on alternatives to the current enforcement-oriented regime of prohibition, and expertise on how to argue for reform. In addition to working with a broad range of media, civil society and professional groups globally, we advise national governments and multilateral organisations, and we hold ECOSOC special consultative status at the UN. www.tdpf.org.uk Our vision An end to the war on drugs and the establishment of an effective system of regulation that promotes health, peace and security, sustainable development and human rights Our mission We will inspire countries to explore and establish the legal regulation of drugs Transform Drug Policy Foundation is a UK-registered charity (#1100518) and limited company (#4862177) Contents How to Regulate Cannabis: Introduction 13 ­ • About this guide 15 Section 1 Foundations 17 • Political context 17 • Aims and principles of effective cannabis regulation 21 • How do we know regulations are fit for purpose? (box) 24 • A spectrum of policy options available 28 • Legal regulation of cannabis markets ˛ what it is and isn»t 31 • Summary of cannabis regulation models 32 • Learning from the successes and failings of alcohol and tobacco regulation 41 • Getting the balance right 43 • Moving forward given what we know, and what we don»t know 44 • Key conclusions and recommendations 46 Section 2 The practical detail of regulation 51 a Production 51 • Summary 51 • Licensing 54 • The Borland ‘Regulated Market Model’ (box) 5 7 • Quality control 59 • Security 61 • Production limits 63 • Smaller-scale production 64 • Spain»s cannabis social clubs (box) 65 • Home growing 68 • Production of cannabis for export 72 b Price 74 • Summary 74 A Practical Guide 7 • Price controls 76 • Impact of legal cannabis prices on the illegal market 80 • Displacement effects of relative price changes 83 c Tax 86 • Summary 86 • Tax options (box) 87 • Tax revenue research and estimates (box) 90 d Preparation and method of consumption 93 • Summary 93 • Preparations 96 • Methods of consumption 9 7 • Recommendations 104 e Strength/potency 114 • Summary 114 • Recommendations 121 f Packaging 125 • Summary 125 • Child resistant packaging 126 • Tamper-proofing 129 • Information on packaging, and packaging design 129 • Packaging information (box) 132 g Vendors 133 • Summary 133 • Socially responsible service training 135 • Shared responsibility between vendor and consumer 138 • Online vendors 139 8 How to Regulate Cannabis: h Purchasers 140 • Summary 140 • Age restrictions on sales 142 • Preventing underage sales 144 • The limitations of age controls 146 • Rationing sales 147 • Purchaser licences/membership schemes 148 • Proof of residency with purchase 150 • Permitted locations for use 150 i Outlets 151 • Summary 151 • Location and outlet density 153 • Appearance and signage 154 • Opening hours 157 • Sale of other drugs 157 • Responsibility for regulatory oversight 158 j Marketing 159 • Summary 159 • Lessons from the regulation of tobacco marketing 161 • Tobacco marketing 162 • Lessons from the regulation of alcohol marketing 164 • Article 13 of the Framework Convention on Tobacco Control 165 • Legal or political constraints on marketing controls 166 • Current cannabis advertising, promotion and sponsorship (CAPS) regulation around the world (box) 168 k Institutions for regulating cannabis markets 169 • International 171 • National government 172 • Local/municipal 174 A Practical Guide 9 Section 3 Key challenges 175 a Cannabis-impaired driving 175 • Summary 175 • Combined use of alcohol and cannabis (box) 179 • Defining and testing impairment 180 • Behavioural assessments 181 • Zero tolerance laws 182 • Fixed threshold limits 183 • Blood testing 186 • Drug testing ˛ different fluids, different results (box) 187 • DUIC and opposition to reform 190 • Recommendations 191 b The interaction of regulatory systems for medical and non-medical uses of cannabis 195 • Summary 195 • Discussion 195 c Synthetic cannabinoids 199 • Summary 199 • Risk profile 201 • Prevalance of use 202 • Regulatory response 203 d Cannabis tourism 205 • Summary 205 • Discussion 206 10 How to Regulate Cannabis: e Cannabis and the UN drug conventions 211 • Summary 211 • Introduction 215 • Background to international cannabis controls 216 • Lessons and ways forward 221 • Options for change 227 1. Treaty reform that applies to all signatory states, requiring consensus approval 231 2. Treaty reform that applies to all signatory states, requiring majority approval 234 3. Treaty reform that applies to a group of states 235 4. Treaty reform that applies to individual states 237 • Implementing cannabis regulation in situations of treaty non-compliance 241 • Side-stepping or denying issues of non-compliance 241 • Discussion and recommendations 246 • Further reading 250 Appendices 251 1 Cannabis regulation around the world 252 2 Further information and contacts 260 Acknowledgements 266 A Practical Guide 11 How to Regulate Cannabis: Introduction This is the second edition of our guide to regulating legal markets for the non-medical use of cannabis. It is for policy makers, drug policy reform advocates and affected communities all over the world who are seeing the question ‘Should we maintain cannabis prohibition?’ moving to ‘What will the regulation framework that replaces prohibition look like?’ This guide builds on Transform’s many years exploring and promoting effective regulation models as alternatives to prohibition. It arrives in a very different world from our landmark 2009 publication After the War on Drugs: Blueprint for Regulation. The cannabis regulation debate is now part of the political mainstream, with multiple jurisdictions at the city, state and country levels , considering, developing and implementing a range of regulated market models for cannabis. These include Spain’s non-profit ‘ cannabis social clubs, commercial enterprises in the US and the Netherlands, and Uruguay’s more government-controlled model. Since the first edition of this guide was published, cannabis reform around the world has continued to accelerate. Two more US states have legalised (and many more are poised to follow, notably including California), Jamaica has legalised cannabis for industrial, medical and religious purposes, and Canada has joined Uruguay in legalising at a national level. This second edition of the guide has a number of updates - including the latest information and analysis from these emerging cannabis policy innovations around the world. For a summary of key regulation models from around the globe see the table on p.252. Transform, working with other colleagues, has produced this guide to help those engaged in cannabis policy through the key practical challenges involved in developing and implementing an effective regulation approach A Practical Guide 13 aimed at achieving the safer, healthier world we all wish to see. A world the so-called ‘war on drugs’ has conspicuously failed to deliver. How to Regulate Cannabis: About this guide The social, political, economic and policy landscape of the many jurisdictions approaching this issue vary widely, and each will need to tailor their policy responses and regulatory models accordingly. So rather than lay out a prescriptive set of regulations detailing a ‘one-size-fits-all’ model, this guide explores the major issues that need to be considered, and the pros and cons of a range of models and responses. It makes broad recommendations that are flexible enough to help those interested in cannabis regulation to develop an approach appropriate to their local circumstances. • Section 1 provides the foundation for a regulatory approach, beginning with the changing political context and ending with some key conclusions and recommendations • Section 2 tackles the detail of how to regulate the various aspects of a cannabis market, including key challenges and broad recommendations for best practice • Section 3 focuses on specific cannabis-related issues that run parallel to wider market regulation questions, nationally and internationally • Appendices include a table comparing key models for cannabis regulation including Uruguay, California, Washington, Colorado, The Netherlands and Spain A Practical Guide 15 How to Regulate Cannabis: Section 1 Foundations Political context The debate around the legalisation and regulation of cannabis has rumbled on ever since the drug was first prohibited. But it is finally nearing its end point. Support for a punitive prohibitionist approach is waning rapidly, while
Load more

Recommended publications
  • Cannabis in New Zealand Perceptions of Use, Users and Policy
    Cannabis in New Zealand perceptions of use, users and policy Geoff Noller A thesis submitted for the degree of Doctor of Philosophy at the University of Otago, Christchurch Aotearoa, New Zealand November 5, 2008 ABSTRACT Introduction Despite humanity’s lengthy relationship with psychoactive substances, their consumption in contemporary societies is perceived as highly problematic. Cannabis, the most commonly imbibed illicit psychotropic, has come to embody these concerns. Medical and scientific research informs notions of use and user, with these being further constructed in the public realm by law, the media and policy against a backdrop of health deficits and other harms including risk taking, criminality and deviance. With many studies drawing on clinical populations, e.g. high intensity users or those in treatment, a pathologized view of the user predominates. Where general population studies incorporate user data, these typically concentrate on the epidemiology of use: frequency, intensity, duration, and symptoms of abuse and dependence. This, however, tells us little about the meaning of use for users or why use continues despite universal official disapprobation. A lack of studies incorporating user perspectives thus ensures the limited focus of much present research and a policy accent on supply reduction at the expense of harm minimisation and safe use education. Those choosing to continue use are stigmatised as deviant or dependant. This has the effect of further bolstering enforcement, a strategy showing little evidence of efficacy. The present study sought a comparison between this dominant discourse on cannabis use and the perspectives of users, with a range of exploratory hypotheses being identified. Method Eighty cannabis-using respondents participated in open-ended face-to-face interviews, of which seventy-six successfully completed a follow-up questionnaire.
    [Show full text]
  • Selling Cannabis Regulation: Learning from Ballot Initiatives in the United States in 2012
    ISSN 2054-1910 Selling cannabis regulation: Learning From Ballot Initiatives in the United States in 2012 Emily Crick*, Mark Cooke¥ and Dave Bewley-Taylorp Policy Brief 6 | November 2014 Key Points • In November 2012, Washington, Colorado, and Oregon voted on ballot initiatives to establish legally regulated markets for the production, sale, use and taxation of cannabis.1 Washington and Colorado’s measures won by wide margins, while Oregon’s lost soundly. • A majority of voters view cannabis in a negative light, but also feel that prohibition for non-medical and non-scientific purposes is not working. As a result, they are more likely to support well-crafted reform policies that include strong regulations and direct tax revenue to worthy causes such as public health and education. • Ballot measures are not the ideal method for passing complicated pieces of legislation, but sometimes they are necessary for controversial issues. Other states often follow in their footsteps, including via the legislature. • The successful campaigns in Washington and Colorado relied on poll-driven messaging, were well organised, and had significant financing. The Oregon campaign lacked these elements. • The Washington and Colorado campaigns targeted key demographic groups, particularly 30-50 year old women, who were likely to be initially supportive of reform but then switch their allegiance to the ‘no’ vote. • Two key messages in Washington and Colorado were that legalisation, taxation and regulation will (i) free up scarce law enforcement resources to focus on more serious crimes and (ii) will create new tax revenue for worthy causes. • National attitudes on legalising cannabis are changing, with more and more people supporting reform.
    [Show full text]
  • The Opportunities Party Real Deal Cannabis Reform
    The Opportunities Party Real Deal Cannabis Reform PART 1: INTRODUCTION Our current drug law is outdated and not fit for purpose. The prohibition model set out under the Misuse of Drugs Act 1975 is a barrier for people seeking help if they need it. Drug addiction, like alcohol addiction tears families apart – but so does our drug law, which not only fails to protect people from harm, but actually adds to it.1 In overhauling this outdated Act The Opportunities Regular usage of cannabis is associated Party has developed an evidenced-based policy with health risk such as: that will more accurately reflect the internationally recognised intention of drug policy – to reduce harm. • problems with healthy brain development among youth; Assessing harm is an area that the current system • depression or anxiety injury; fails to effectively do. While the goal of the current • symptoms of chronic bronchitis;2 criminalisation policy is harm-minimisation based on the familiar strategies of controlling supply, However as with alcohol and cigarettes, reducing demand and limiting the problem – it fails abstinence is unrealistic. Prohibition flies in the to account for the effects of exposing users and face of popular demand and leads to illicit supply growers to gangs and to the criminal justice system. and usage.3 The evidence shows that criminalisation The evidence is mounting that these consequences of cannabis has had no significant statistical impact have greater detrimental impacts than those from on reducing use, nor is there any evidence that cannabis use itself. The criminalisation approach decriminalisation increases use.4, 5, 6, 7 The health also ties up criminal justice resources that could risks listed above are still prevalent with or without be more effectively directed elsewhere.
    [Show full text]
  • Candidate General Scorecard.Xlsx
    Office Sought Ballot Name US SENATOR - R John Barrasso US SENATOR - D Gary Trauner A A A A B A A A A US REP - R Liz Cheney US REP - D Greg Hunter A A A A A A A A A 1) Industrial hemp (marijuana plants with no THC) should be moved off of the Schedule 1 drug list. 2) Medical marijuana should be an available choice for individuals with life-threatening conditions. 3) Medical marijuana should be available to individuals who have chronic conditions such as seizure disorders, chonic pain, GOVERNOR - R Mark Gordon and severe autism. 4) Decriminalization: Giving those caught with maijuana fines instead of jail time is a good idea. GOVERNOR - D Mary A. Throne B A A A D C A A A SECRETARY OF STATE - R Edward Buchanan B A A F F D A C B 5) Legalization: Marijuana should be legal to consume as long as the person is over 21. SECRETARY OF STATE - D James W. Byrd A A A A D D B B A STATE AUDITOR - R Kristi Racines STATE AUDITOR - D Jeff Dockter A A A A A B A A A Should be available period. 6) The extra money Wyoming would receive from taxing marijuana sales makes legalization a financially smart move. STATE TREASURER - R Curt Meier SUPT. OF SCHOOLS - R Jillian Balow STATE SENATOR 01 - R Ogden Driskill STATE SENATOR 03 - R Cheri E. Steinmetz Declined 7) Do you support medical marijuana? STATE SENATOR 03 - D Marci Shaver Declined STATE SENATOR 05 - R Lynn Hutchings B B B C F F C B B STATE SENATOR 07 - R Stephan A.
    [Show full text]
  • The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
    TRANSNATIONAL I N S T I T U T E THE RISE AND DECLINE OF CANNABIS PROHIBITION THE HISTORY OF CANNABIS IN THE UN DruG CONTROL SYSTEM AND OPTIONS FOR REFORM 3 The Rise and Decline of Cannabis Prohibition Authors Dave Bewley-Taylor Tom Blickman Martin Jelsma Copy editor David Aronson Design Guido Jelsma www.guidojelsma.nl Photo credits Hash Marihuana & Hemp Museum, Amsterdam/ Barcelona Floris Leeuwenberg Pien Metaal UNOG Library/League of Nations Archives UN Photo Printing Jubels, Amsterdam Contact Transnational Institute (TNI) De Wittenstraat 25 1052 AK Amsterdam Netherlands Tel: +31-(0)20-6626608 Fax: +31-(0)20-6757176 [email protected] www.tni.org/drugs www.undrugcontrol.info www.druglawreform.info Global Drug Policy Observatory (GDPO) Research Institute for Arts and Humanities Rooms 201-202 James Callaghan Building Swansea University Financial contributions Singleton Park, Swansea SA2 8PP Tel: +44-(0)1792-604293 This report has been produced with the financial www.swansea.ac.uk/gdpo assistance of the Hash Marihuana & Hemp Museum, twitter: @gdpo_swan Amsterdam/Barcelona, the Open Society Foundations and the Drug Prevention and Information Programme This is an Open Access publication distributed under (DPIP) of the European Union. the terms of the Creative Commons Attribution License The contents of this publication are the sole responsibility (http://creativecommons.org/licenses/by/2.0), which of TNI and GDPO and can under no circumstances be permits unrestricted use, distribution, and reproduction regarded as reflecting the position of the donors. in any medium, provided the original work is properly cited. TNI would appreciate receiving a copy of the text in which this document is used or cited.
    [Show full text]
  • TY18:Layout 1 17/08/09 16:06 Pagina 1 TY18:Layout 1 17/08/09 16:06 Pagina 2 TY18:Layout 1 17/08/09 16:06 Pagina 3 TY18:Layout 1 17/08/09 16:06 Pagina 4
    TY18:Layout 1 17/08/09 16:06 Pagina 1 TY18:Layout 1 17/08/09 16:06 Pagina 2 TY18:Layout 1 17/08/09 16:06 Pagina 3 TY18:Layout 1 17/08/09 16:06 Pagina 4 Publisher/ Editor in Chief Marco Renda [email protected] Assistant to Editor Jef Tek [email protected] Copy Editor Aendrew Rininsland [email protected] Magazine design & layout Ivan Art [email protected] Director of Sales & Marketing Michelle Rainey [email protected] Technical Writer Ally a.k.a Pflover [email protected] Q&A Advisor Shantibaba [email protected] Text & photography Contributors Marco Renda, Ændrew Rininsland, Ivan Art, Michelle Rainey, Otto Snow, PFlover, Jef Tek, Shantibaba, Jerry B., Soma, Jay Generation, Harry Resin, Dr Dog, Chris Thompson, Jeremy Norrie, Keith Fagin, John (Shiva), Lara Lesack, Richard Owl Mirror, Suggarpaw, British Hempire, Jackie Sutton, Salvatore Messina HD., David B. Allen M.D., Hashmasta-Kut, Ale Keppel, Gregorio “Goyo” Fernandez Cover Pic `Mr Nice Critical Mass flower at 6 weeks` by Gregorio Fernandez “Goyo” for Mr. Nice Seedbank Submissions [email protected] Treating Yourself 250 The East Mall, P.O. Box 36531 Etobicoke, Ontario M9B 3Y8 Canada T: + 416 620 1951 F: +416 620 0698 Printed in Canada 4 - Treating Yourself, Issue 18- 2009 TY18:Layout 1 17/08/09 16:06 Pagina 5 Marco’s Editorial Well I have to say issue number 17 certainly caused a lot of controversy, especially surrounding the Dr Frankenbeanstien article. Both Sam The Skunkman and Ed Rosenthal contacted me regarding this. I offered them both the chance to rebut what was published, but they declined to do so.
    [Show full text]
  • Manifiesto Internacional OMS Cannabis Traducido 1:12
    Naciones Unidas E/CN.7/2020/NGO/7 Distr.: General Consejo Ecónomico y Social 25 November 2020 English only Comisión en drogas narcóticas Reanudada la sexagésimo tercera sesión Vienna, 2–4 diciembre 2020 Item 5 de la agenda provisional* Implementación de tratados de control de drogas internacionales Declaración presentada por la coalición europea por la justicia y políticas de drogas eficaces, una organización no gubernamental reconocida como entidad consultiva por el Consejo Social y Económico El Secretario-General ha recibido el siguiente manifiesto, el cual está siendo circulado de acuardo a los párrafos 36 y 37 de la resolución 1996/31 del Consejo Económico y Social __________________ * E/CN.7/2020/1/Add.1. ** Issued without formal editing. V.20-06992 (E) 261120 291120 *2006992* E/CN.7/2020/NGO/7 Manifiesto Apoya el acceso de pacientes a su medicina, ¡vota que sí! La cannabis ha sido una medicina convencional desde el amanecer de la civilización. En 1902 y 1929 las medicinas cannábicas fueron discutidas en la Conferencia Internacional por la Unificación de las Fórmulas Farmacopeicas para Drogas Potentes, la cual proporcionó pautas para armonizar las medicinas de cannabis y proveer a pacientes de drogas seguras y estandarizadas para sus tratamientos. Para este tiempo la cannabis ya era bastante aceptada en la práctica clínica y había sido reportada en las Farmacopeas de Austria, Bélgica, Francia, Hungaria, Italia, Japón, Holanda, Suiza, Reino Unido, Estados Unidos de América, así como en México y España. En 1958, las Naciones Unidas reportaron que la cannabis estaba también en las Farmacopeas de Argentina, Brazil, China, Egypt, Finland, India, Portugal, Romania, la URSS, y Venezuela.(2) Muchas preparacionas cannábicas están en textos ancestrales que componen la Farmacopea Ayurvédica (Charaka Samhita, Sushruta Samhita, Shargandhara Samhita) y en las Farmacopeas Mediterráneas de Umdat at-tabîb, Jami' al-mufradat, Hadîqat al-azhâr or Tuhfat al-ahbâb.
    [Show full text]
  • The Highs and Lows of Cannabis Law Reform
    THE HIGHS AND LOWS OF CANNABIS LAW REFORM Presented by the Equal Justice Project Access Team 2020 Written By: Hurya Ahmad, Greer Bonnette, Jonathan de Jongh, Vivian del Carpio, Gwen Hamilton, Jungwon Jo, Amanda Joshua, Jayna Lee, Tanzeel Patel, Kannu Sachdev, Jess Thwaites-Hardy and Helena Wiseman Special thanks to the Equal Justice Project Communications team for their assistance in editing and compilation This work was undertaken by several volunteers of the Equal Justice Project based on personal research from a variety of official and unofficial sources. No information within this symposium paper will be understood as official. The Equal Justice Project makes no representations as to the accuracy or completeness of any information on this site or found by following any link on this site. The Equal Justice Project will not be liable for any errors or omissions in this information nor for the availability of this information. THE HIGHS AND LOWS OF THE CANNABIS REFERENDUM CONTENTS Historical Development on the Law on Cannabis in New Zealand 1 Current Legislation 2 Current Policy 3 International Comparison 4 Recreational Use and Regulation 5 Arguments for the Bill 6 1. Regulation 2. Improved Justice Outcomes 3. Economic Benefits Arguments against the Bill 7 1. The Black Market 2. Adverse Effects on Youth 3. Employment Issues THE HIGHS AND LOWS OF THE CANNABIS REFERENDUM HISTORICAL DEVELOPMENT The history of cannabis legislation in New Zealand reveals various paradigm shifts in the law over time. The country was one of the very few areas where the United Kingdom discouraged CONTENTS industrial hemp production, as the harakeke plant was thought to be an adequate alternative for fibre.
    [Show full text]
  • Islam and Cannabis Legalisation and Religious Debate in Iran
    International Journal of Drug Policy 56 (2018) 121–127 Contents lists available at ScienceDirect International Journal of Drug Policy journal homepage: www.elsevier.com/locate/drugpo Research Paper Islam and cannabis: Legalisation and religious debate in Iran T ⁎ Maziyar Ghiabia, , Masoomeh Maarefvandb,c, Hamed Baharib, Zohreh Alavic a Ecole des Hautes Etudes en Sciences Sociales, 54 Boulevard Raspail, 75006, Paris, France b Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran c Department of Social Work, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran ARTICLE INFO ABSTRACT Keywords: Iran is currently discussing cannabis and opium regulations, which could bring a legalisation of drug consumption Religion through a state supervised system. The article engages with the question of cannabis by looking at the legal interpretation Cannabis of religious authorities in the Islamic Republic of Iran. The choice of Iran is justified for several reasons: firstly, Iran has a Legalisation long history of drug use and cannabis has been part of the country’sintoxicanttraditionssincetimesimmemorial; Regulation secondly, the Iranian state is unique in that it combines religious exegesis with political machination through official Iran channels; finally, among all Middle East and Islamic countries, Iran is at the avant-garde in experimenting in the field of Middle east Islamic law drugs policy which makes an excellent case for the study of cannabis regulation. The article is the result of a direct History of cannabis engagement with Iran’sleadingShi’a authorities, the maraje’-e taqlid, ‘source of emulation’. The authors redacted a list of eight questions (estefta’at) about the status of cannabis in Iranian society.
    [Show full text]
  • Medical Marijuana the War on Drugs and the Drug Policy Reform Movement
    UNIVERSITY OF CALIFORNIA SANTA CRUZ FROM THE FRONTLINES TO THE BOTTOM LINE: MEDICAL MARIJUANA THE WAR ON DRUGS AND THE DRUG POLICY REFORM MOVEMENT A dissertation submitted in partial satisfaction Of the requirements for the degree of DOCTOR OF PHILOSOPHY in SOCIOLOGY by Thomas R. Heddleston June 2012 The Dissertation of Thomas R. Heddleston is approved: ____________________________________ Professor Craig Reinarman, Chair ____________________________________ Professor Andrew Szasz ____________________________________ Professor Barbara Epstein ___________________________________ Tyrus Miller Vice Provost and Dean of Graduate Studies Copyright © by Thomas R. Heddleston 2012 TABLE OF CONTENTS Introduction 1 Chapter I: The History, Discourse, and Practice of Punitive Drug Prohibition 38 Chapter II: Three Branches Of Reform, The Drug Policy Reform Movement From 1964 To 2012 91 Chapter III: Sites of Social Movement Activity 149 Chapter IV: The Birth of Medical Marijuana In California 208 Chapter V: A Tale of 3 Cities Medical Marijuana 1997-2011 245 Chapter VI: From Movement to Industry 303 Conclusion 330 List of Supplementary Materials 339 References 340 iii LIST OF TABLES AND FIGURES Table 2.1: Major Organizations in the Drug Policy Reform Movement by Funding Source and Organizational Form 144 Table 3.1: Characteristics of Hemp Rallies Attended 158 Table 3.2: Drug Policy Organizations and the Internet 197 Figure 4.1: Proposition 215 Vote November 1996 241 Table 5.1: Political Opportunity Structures and Activist Tools 251 Table 5.2: Key Aspects of Political Opportunity Structures at 3 Levels of Government 263 Figure 5.1: Medical Cannabis Dispensaries by Region and State 283 iv ABSTRACT Thomas R. Heddleston From The Frontlines to the Bottom Line: Medical Marijuana the War On Drugs and the Drug Policy Reform Movement The medical marijuana movement began in the San Francisco Bay Area in the early 1990s in a climate of official repression.
    [Show full text]
  • New Zealanders Experiences of Cannabis in Amsterdam While on Their Overseas Experience (OE)
    Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and private study only. The thesis may not be reproduced elsewhere without the permission of the Author. i Flight of the Kiwi New Zealanders experiences of Cannabis in Amsterdam while on their Overseas Experience (OE) A thesis presented in partial fulfilment of the requirements for the Degree of Masters in Health Psychology At Massey University Manawatu New Zealand. Gabrielle Margaret Colley 2019 ii Abstract Cannabis consumption and travelling share a number of similarities, such as evoking pleasure or anxiety and, like in the title used to reflect this thesis, represent the experience of “flight” for the “Kiwi” (New Zealander). This thesis therefore explores both the experiences of cannabis consumption, a flight of the mind and travelling a flight of the body. The aim was to understand how New Zealanders experience cannabis in Amsterdam while they are undertaking a working holiday based in the United Kingdom (UK), known within Aotearoa New Zealand as an Overseas Experience (OE). Given Aotearoa New Zealand’s current political debates on cannabis control and the upcoming 2020 public referendum on legalising the substance, this thesis provides an opportunity to explore how New Zealanders experience cannabis within a liberal country that tolerates the sale of soft drugs in licensed premises, while growing up in a country that enforces cannabis prohibition. Statistics on cannabis use illustrate a steady rise in global consumption, however majority of countries still implement prohibition as a method of control, therefore choosing to study New Zealanders use of cannabis in a country without any legal ramification or stigmatisation for personal consumption allowed for greater transparency and in depth exploration.
    [Show full text]
  • Crime and the Legalization of Recreational Marijuana
    DISCUSSION PAPER SERIES IZA DP No. 10522 Crime and the Legalization of Recreational Marijuana Davide Dragone Giovanni Prarolo Paolo Vanin Giulio Zanella JANUARY 2017 DISCUSSION PAPER SERIES IZA DP No. 10522 Crime and the Legalization of Recreational Marijuana Davide Dragone Giulio Zanella University of Bologna University of Bologna and IZA Giovanni Prarolo University of Bologna Paolo Vanin University of Bologna JANUARY 2017 Any opinions expressed in this paper are those of the author(s) and not those of IZA. Research published in this series may include views on policy, but IZA takes no institutional policy positions. The IZA research network is committed to the IZA Guiding Principles of Research Integrity. The IZA Institute of Labor Economics is an independent economic research institute that conducts research in labor economics and offers evidence-based policy advice on labor market issues. Supported by the Deutsche Post Foundation, IZA runs the world’s largest network of economists, whose research aims to provide answers to the global labor market challenges of our time. Our key objective is to build bridges between academic research, policymakers and society. IZA Discussion Papers often represent preliminary work and are circulated to encourage discussion. Citation of such a paper should account for its provisional character. A revised version may be available directly from the author. IZA – Institute of Labor Economics Schaumburg-Lippe-Straße 5–9 Phone: +49-228-3894-0 53113 Bonn, Germany Email: [email protected] www.iza.org IZA DP No. 10522 JANUARY 2017 ABSTRACT Crime and the Legalization of Recreational Marijuana We provide first-pass evidence that the legalization of the cannabis market across US states may be inducing a crime drop.
    [Show full text]